Rosa DeLauro (D-CT) - Should Congress strengthen regulations on direct-to-consumer advertising?

DeLauro sponsored H.R. 6151 to impose restrictions on drug ads.

H.R. 6151: To amend the Federal Food, Drug, and Cosmetic Act with respect to drug and device advertising, and for other purposes

Sponsor: Rep. Rosa DeLauro [D-CT]

Here's part of it:

SEC. 503C. DIRECT-TO-CONSUMER DRUG OR DEVICE ADVERTISING.

`(a) Prohibitions-

`(1) FIRST THREE YEARS-

`(A) IN GENERAL- Subject to subparagraph (B), no person shall conduct direct-to-consumer advertising of--

`(i) a drug for which an application is submitted under section 505(b) before the end of the 3-year period beginning on the date of the approval of such application; or

`(ii) a class II or class III device for which a premarket notification is submitted under section 510(k) or a class III device for which a premarket approval is sought under section 515, before the end of the 3-year period beginning on the date of the notification or approval, respectively.